Sun Pharma
-
Bayer, Sun Pharma in marketing and distribution agreement for second brand of Finerenone in India
Finerenone was first launched by Bayer in India in August 2022 under the brand name Kerendia, Sun Pharma to market…
Read More » -
IPA’s 8th Global Pharmaceutical Quality Summit concludes in Mumbai
The focus of the event was on patient centricity and the future of manufacturing and quality The Indian Pharmaceutical Alliance…
Read More » -
Sun Pharma to launch oral lipid-lowering drug Brillo in India
The drug is indicated for people who have an inherited genetic disorder that causes high cholesterol levels Sun Pharmaceutical Industries…
Read More » -
Sun Pharma posts net profit of Rs 20,588 M in Q3FY22
The gross sales is at Rs 98,142 million Sun Pharmaceutical Industries has reported financials for the third quarter ending December…
Read More » -
Sun Pharma, Lupin recall products in US
Sun Pharma is recalling 22,752 blister packs of Loratadine-D extended-release tablets and Lupin is recalling 16,272 bottles of Gatifloxacin Ophthalmic…
Read More » -
Pharma majors collaborate for clinical trial of Molnupiravir for COVID-19 treatment
The five pharma companies will jointly sponsor, supervise and monitor the clinical trial in India Cipla, Dr Reddy’s, Emcure, Sun…
Read More » -
Cipla, Sun Pharma in licensing agreement with Lilly
To expand access to COVID-19 treatment in India Cipla and Sun Pharma have signed a royalty-free, non-exclusive voluntary licensing agreement…
Read More » -
Drug makers told to ramp up remdesivir production: Govt
The direction comes against reports of shortages of the critical drug The government said that all seven manufacturers of remdesivir…
Read More » -
Pharma majors invest Rs 40 crore each in ABCD Technologies
ABCD Technologies will be renamed as IndoHealth Services Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma have subscribed…
Read More »